Cadmium oxide nanoparticles (CdO NPs) are employed in optoelectronic devices and
as a starting material for generating quantum dots as well as for medical imaging and targeting
of pharmaceutical agents to disease sites. However, there are lack of data concerning short- and
long-term effects of CdO NPs on the lungs